Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
about
Expression of antizyme inhibitor 2 in mast cells and role of polyamines as selective regulators of serotonin secretionAntizyme inhibitor 2 (AZIN2/ODCp) stimulates polyamine uptake in mammalian cellsRegulation of all members of the antizyme family by antizyme inhibitorIdentification of genes involved in ceramide-dependent neuronal apoptosis using cDNA arrays.Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious useCrystallographic and biochemical studies revealing the structural basis for antizyme inhibitor functionStructural Insight into DFMO Resistant Ornithine Decarboxylase from Entamoeba histolytica: An Inkling to Adaptive EvolutionDiscovery of a spermatogenesis stage-specific ornithine decarboxylase antizyme: antizyme 3Polyamines regulate both transcription and translation of the gene encoding ornithine decarboxylase antizyme in mouseAntizyme2 is a negative regulator of ornithine decarboxylase and polyamine transportMouse ornithine decarboxylase-like gene encodes an antizyme inhibitor devoid of ornithine and arginine decarboxylating activityCharacterization of the Entamoeba histolytica ornithine decarboxylase-like enzymeStructure, organization and expression of the mouse ornithine decarboxylase antizyme geneAntizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppressionStructural and degradative aspects of ornithine decarboxylase antizyme inhibitor 2.Critical factors governing the difference in antizyme-binding affinities between human ornithine decarboxylase and antizyme inhibitor.ATP-Dependent inactivation and sequestration of ornithine decarboxylase by the 26S proteasome are prerequisites for degradationMinimal antizyme peptide fully functioning in the binding and inhibition of ornithine decarboxylase and antizyme inhibitor.Functional roles of the dimer-interface residues in human ornithine decarboxylase.Ornithine decarboxylase antizyme induces hypomethylation of genome DNA and histone H3 lysine 9 dimethylation (H3K9me2) in human oral cancer cell line.Antizyme restrains centrosome amplification by regulating the accumulation of Mps1 at centrosomesDistribution patterns of ornithine decarboxylase in cells and tissues: facts, problems, and postulates.Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer.Knockdown of ornithine decarboxylase antizyme 1 causes loss of uptake regulation leading to increased N1, N11-bis(ethyl)norspermine (BENSpm) accumulation and toxicity in NCI H157 lung cancer cells.Control of Polyamine Biosynthesis by Antizyme Inhibitor 1 Is Important for Transcriptional Regulation of Arginine Vasopressin in the Male Rat Hypothalamus.Structural basis of antizyme-mediated regulation of polyamine homeostasis.Knockdown of antizyme inhibitor decreases prostate tumor growth in vivouORFs with unusual translational start codons autoregulate expression of eukaryotic ornithine decarboxylase homologsPneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages.Critical factors determining dimerization of human antizyme inhibitor.Protein RS1 (RSC1A1) Downregulates the Exocytotic Pathway of Glucose Transporter SGLT1 at Low Intracellular Glucose via Inhibition of Ornithine Decarboxylase.Differential expression of ornithine decarboxylase antizyme inhibitors and antizymes in rodent tissues and human cell lines.Putrescine independent wound response phenotype is produced by ODC-like RNAi in planarians.Degradation of antizyme inhibitor, an ornithine decarboxylase homologous protein, is ubiquitin-dependent and is inhibited by antizyme.Cell culture analysis of the regulatory frameshift event required for the expression of mammalian antizymes.Polyamine regulation of ornithine decarboxylase and its antizyme in intestinal epithelial cells.Two zebrafish (Danio rerio) antizymes with different expression and activitiesAgmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels.Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma.Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines, but does not prevent cardiac hypertrophy.
P2860
Q24311326-D2B59A84-5D99-4961-BA6F-79EEC1C3556CQ24317020-750E546A-0B79-4C8D-A4F2-C38E2391FD5EQ24528148-63572BE6-21C5-4D6A-B4E1-5AF3836F1574Q24802601-067B730E-6F78-4BA6-9E0A-F2CCB2578C9EQ26970809-25752FF5-7CE7-4B04-8DBC-04599FAFBF3EQ27650167-4F03EAA1-B8F1-4247-9B68-BAF9DFFE84CCQ27675929-279FE472-DCD4-4799-A3F9-60D091CC6C45Q28115211-C79D9431-0F58-44AD-9C2E-359D72CB361CQ28116450-D2943002-30B9-41A4-8C30-C147AF757FADQ28143773-B7F64435-7D07-4730-BBFD-C137AC04674AQ28258468-AB303E24-716F-4E0E-90F5-37EE4CF244F7Q28472105-2E5F2AE8-1A5C-42E9-ADA8-C3E6D1599B92Q28507972-6C28E5F0-2572-4097-8854-3C17F93FDFE2Q28513325-B7F12458-04BC-4EF7-856F-9B3A7907B4B5Q29347303-75D95EE7-57CB-49DB-93F9-768942A5326FQ33892549-AB8891B7-F532-4D00-A363-FA7EAAC73B87Q33959864-67B8CFA7-B1AA-4C96-9586-A5CBE6A946BAQ34023433-75EC0855-F7BE-4A88-BFBB-7CDB7371BA10Q34070766-D14FC157-CC1F-416C-B448-D58B61B86EF2Q34103537-DC611E3C-D884-40DC-85DD-E4385490CDE2Q34313419-06BB4D41-99B3-426A-85A6-32CD28ED9157Q34788182-15AF0C77-F4F3-4045-9949-E1FF49328935Q35386279-924DE399-F564-4044-B709-22E7EA56CC45Q35618959-9AFC1CF2-9479-4AAD-983B-8BE5CE63ACE1Q35878827-B9F25EE3-093A-4B1C-BF57-F994D9CB5A49Q36056787-87E6ACE9-B689-4426-A6BE-A1C8F822F152Q36638469-CBD2E1CC-35B2-4D9C-9F1C-DB56646E45EEQ36786825-12B54FC2-3028-4174-BCCE-BE02EF1749A3Q37134470-9FFE29F8-F980-4B1F-B249-F8AD95A1860DQ37446803-B2F339B7-7658-4653-9C03-E9FFACFB7492Q39459400-30FB94FC-EDE6-4301-B3A6-2E00194F1BF6Q39495489-2558B65E-EBFC-4566-AA11-95C13674D618Q40075640-4D6EC6A0-8F19-470F-AFFE-4E50FC6B1CA8Q40502823-AF22E2CF-958E-4FB8-9D1C-4FAC356B719BQ40762409-B338A9CD-06F5-444B-8EA8-F2CFDBA22C89Q40836507-016C5D10-AF72-4B62-AD4F-0F20D43B665BQ40910669-D80A4B72-F878-4668-9A59-B70E009D8B72Q41032347-65992E91-1AFF-47FB-9C7D-F50FBDB4BE5BQ41107342-DDA65961-6DF0-415E-91AE-35AC93CA6919Q41821808-7527CC25-019F-4E22-9A39-47B5F60F9604
P2860
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
description
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1996
@ast
im Februar 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1996/02/16)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/02/16)
@nl
наукова стаття, опублікована в лютому 1996
@uk
name
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
@ast
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
@en
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
@nl
type
label
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
@ast
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
@en
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
@nl
prefLabel
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
@ast
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
@en
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
@nl
P2093
P2860
P3181
P356
P1476
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase
@en
P2093
S. Hayashi
S. Matsufuji
Y. Murakami
P2860
P304
P3181
P356
10.1074/JBC.271.7.3340
P407
P577
1996-02-16T00:00:00Z